Michael Hennig

Michael Hennig

Company: LeadXpro AG

Job title: Chief Executive Officer


Enabling Structure-Based Drug Discovery on GPCRs 12:00 pm

Protein engineering strategies for enhancement of expression and stability Biophysical methods to characterize small-molecule ligand binding Selecting EM and/or X-ray for structure research to investigate ligand interaction Time resolved X-ray crystallography to investigate receptor dynamicsRead more

day: Day One Track B AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.